Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dermorphin, (2-l-ala)-isomer
2. H-tyr-d-ala-phe-gly-tyr-pro-ser-nh2
3. Tyrosyl-alanyl-phenylalanyl-glycyl-tyrosyl-prolyl-serinamide
1. 77614-16-5
2. H-tyr-d-ala-phe-gly-tyr-pro-ser-nh2
3. (2s)-n-[(2s)-1-amino-3-hydroxy-1-oxopropan-2-yl]-1-[(2s)-2-[[2-[[(2s)-2-[[(2r)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxamide
4. Chembl278789
5. 2sec01b703
6. Tyr-d-ala-phe-gly-tyr-pro-ser-nh2
7. Dermorphin Acetate
8. Tyrosyl-alanyl-phenylalanyl-glycyl-tyrosyl-prolyl-serinamide
9. Unii-2sec01b703
10. Yafgyps-nh2
11. Schembl237169
12. Tyr-ala-phe-gly-tyr-pro-ser
13. Dtxsid40228281
14. Chebi:177767
15. Hy-p0244
16. Bdbm50059841
17. Tyr-dala-phe-gly-tyr-pro-ser-nh2
18. Zinc95548678
19. C20030
20. Q1771654
21. L-serinamide, L-tyrosyl-d-alanyl-l-phenylalanylglycyl-l-tyrosyl-l-prolyl-
22. (s)-1-[(s)-2-[2-((s)-2-{(r)-2-[(s)-2-amino-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-3-phenyl-propionylamino)-acetylamino]-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylic Acid ((s)-1-carbamoyl-2-hydroxy-ethyl)-amide
23. (s)-n-((s)-1-amino-3-hydroxy-1-oxopropan-2-yl)-1-((2s,8s,11r,14s)-14-amino-8-benzyl-2-(4-hydroxybenzyl)-15-(4-hydroxyphenyl)-11-methyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazapentadecane)pyrrolidine-2-carboxamide
24. 1-[2-[2-(2-{2-[2-amino-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-3-phenyl-propionylamino)-acetylamino]-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylic Acid (1-carbamoyl-2-hydroxy-ethyl)-amide
25. 1-[2-[2-(2-{2-[2-amino-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-3-phenyl-propionylamino)-acetylamino]-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylic Acid (1-carbamoyl-2-hydroxy-ethyl)-amide (dermorphin)
26. 1-[2-[2-(2-{2-[2-amino-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-3-phenyl-propionylamino)-acetylamino]-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylic Acid (1-carbamoyl-2-hydroxy-ethyl)-amide(dermorphin)
27. Dermorphin;1-[2-[2-(2-{2-[2-amino-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-3-phenyl-propionylamino)-acetylamino]-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylic Acid (1-carbamoyl-2-hydroxy-ethyl)-amide
| Molecular Weight | 802.9 g/mol |
|---|---|
| Molecular Formula | C40H50N8O10 |
| XLogP3 | 0 |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 19 |
| Exact Mass | 802.36498982 g/mol |
| Monoisotopic Mass | 802.36498982 g/mol |
| Topological Polar Surface Area | 296 Ų |
| Heavy Atom Count | 58 |
| Formal Charge | 0 |
| Complexity | 1410 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
ABOUT THIS PAGE
80
PharmaCompass offers a list of Dermorphin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dermorphin manufacturer or Dermorphin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dermorphin manufacturer or Dermorphin supplier.
PharmaCompass also assists you with knowing the Dermorphin API Price utilized in the formulation of products. Dermorphin API Price is not always fixed or binding as the Dermorphin Price is obtained through a variety of data sources. The Dermorphin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dermorphin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dermorphin, including repackagers and relabelers. The FDA regulates Dermorphin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dermorphin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dermorphin supplier is an individual or a company that provides Dermorphin active pharmaceutical ingredient (API) or Dermorphin finished formulations upon request. The Dermorphin suppliers may include Dermorphin API manufacturers, exporters, distributors and traders.
click here to find a list of Dermorphin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dermorphin DMF (Drug Master File) is a document detailing the whole manufacturing process of Dermorphin active pharmaceutical ingredient (API) in detail. Different forms of Dermorphin DMFs exist exist since differing nations have different regulations, such as Dermorphin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dermorphin DMF submitted to regulatory agencies in the US is known as a USDMF. Dermorphin USDMF includes data on Dermorphin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dermorphin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dermorphin suppliers with USDMF on PharmaCompass.
Dermorphin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dermorphin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dermorphin GMP manufacturer or Dermorphin GMP API supplier for your needs.
A Dermorphin CoA (Certificate of Analysis) is a formal document that attests to Dermorphin's compliance with Dermorphin specifications and serves as a tool for batch-level quality control.
Dermorphin CoA mostly includes findings from lab analyses of a specific batch. For each Dermorphin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dermorphin may be tested according to a variety of international standards, such as European Pharmacopoeia (Dermorphin EP), Dermorphin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dermorphin USP).
